Benjamin Walbaum
Overview
Explore the profile of Benjamin Walbaum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Acevedo F, Walbaum B, Camus M, Manzor M, Muniz S, Medina L, et al.
Breast Cancer Res Treat
. 2023 Mar;
199(2):363-370.
PMID: 36988750
Purpose: Latin American reports on genetic cancer risk assessments are scarce. In Chile, current breast cancer (BC) guidelines do not define strategies for germline genetic testing. Our study sought to...
12.
Acevedo F, Walbaum B, Muniz S, Petric M, Martinez R, Guerra C, et al.
Sci Rep
. 2022 Dec;
12(1):21145.
PMID: 36477462
Pathological complete response (pCR) after neoadjuvant chemotherapy (NCT) is associated with good long-term prognosis in breast cancer (BC) patients. However, some patients still recur and eventually die from this disease....
13.
Acevedo F, Walbaum B, Medina L, Merino T, Camus M, Puschel K, et al.
Breast Cancer Res Treat
. 2022 Nov;
197(2):449-459.
PMID: 36414796
Background: Latin American (LA) studies on triple-negative breast cancer (TNBC) and their characteristics are scarce. This forces physicians to make clinical decisions based on data obtained from studies that include...
14.
Canteros D, Walbaum B, Cordova-Delgado M, Torrealba A, Reyes C, Navarro M, et al.
Ecancermedicalscience
. 2022 Aug;
16:1396.
PMID: 35919242
Introduction: Recently, contrast-enhanced mammography (CEM) has emerged as a reliable alternative to breast magnetic resonance imaging (MRI) for the assessment of pathological response in breast cancer patients. Our study sought...
15.
Ward Z, Walbaum M, Walbaum B, Guzman M, de la Jara J, Nervi B, et al.
Lancet Oncol
. 2021 Sep;
22(10):1427-1437.
PMID: 34487693
Background: The COVID-19 pandemic has strained health system capacity worldwide due to a surge of hospital admissions, while mitigation measures have simultaneously reduced patients' access to health care, affecting the...
16.
Walbaum B, Puschel K, Medina L, Merino T, Camus M, Razmilic D, et al.
Breast Cancer Res Treat
. 2021 Jul;
189(2):561-569.
PMID: 34244869
Purpose: The implementation of national breast cancer (BC) screening programs in Latin America has been rather inconsistent. Instead, most countries have opted for "opportunistic" mammogram screenings on the population at...
17.
Acevedo F, Petric M, Walbaum B, Robin J, Legorburu L, Murature G, et al.
Ecancermedicalscience
. 2021 Mar;
15:1185.
PMID: 33777178
Introduction: There is extensive evidence associating the response to neoadjuvant chemotherapy (NeoCT) with breast cancer (BC) survival. However, to the author's knowledge, there is no published data in Chile. The...
18.
Walbaum B, Acevedo F, Medina L, Loreto Bravo M, Merino T, Camus M, et al.
Ecancermedicalscience
. 2021 Mar;
15:1178.
PMID: 33777171
Background: Breast cancer (BC) is the leading cause of cancer death for Chilean women. About 11% of cases are triple-negative (TN) BC. These are characterised by poor prognosis, higher risk...
19.
Walbaum B, Acevedo F, Medina L, Loreto Bravo M, Merino T, Camus M, et al.
Curr Med Res Opin
. 2020 May;
36(7):1195-1199.
PMID: 32351137
Clinical guidelines recommend the use of endocrine therapy (ET) in advanced hormone receptor positive (HR+) human epidermal growth factor receptor type 2 negative (HER2-) breast cancer (BC) patients in the...
20.
Pizarro G, Pinto M, Munoz-Medel M, Cordova-Delgado M, Loreto Bravo M, Nervi B, et al.
Clin Lung Cancer
. 2020 Feb;
21(4):e250-e254.
PMID: 32088114
No abstract available.